24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Licensing
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
21:46
High-tech entrepreneur Moshe Yanai’s debts balloon to $250 million
21:24
"A Robin Hood movement to help the smaller developers": How Appcharge is fighting app store monopolies
17:13
Full list of Israeli high-tech funding rounds in 2026
17:09
Israeli startup bets on psychedelic mushrooms for mental health treatment
More stories
Buzz
Most popular
Daily
Weekly
1
The 50 most promising Israeli startups - 2026
2
From Iron Dome to Arrow missiles, unpaid bills accumulate in Israel’s defense sector
3
Five bidders advance in Nice’s $2.5 billion Actimize sale process
4
“Israel will remain a cyber powerhouse for the next decade”
5
SanDisk’s second act: An AI boom, a $160 billion valuation, and a deep Israeli thread
More news
Licensing
4 stories about Licensing
Israeli roads off-limits to Tesla Cybertruck due to licensing issues
18.07.24
|
Tomer Hadar
Ministry of Transportation holds back approval over bulletproof concerns
“Licensing practices are tilting the market in favor of certain providers against others”
07.05.22
|
James Spiro
Francisco Mingorance, Executive General at CISPE, explains how cloud monopolies are affecting licensing agreements online
Israel to Set Up Fast Track for Licensing Fintech Projects
19.08.19
|
Meir Orbach
According to the Israeli Ministry of Finance, there are currently 2,000 different entities awaiting licensing, many of which are fintech and blockchain companies that need to make only slight adjustments to comply with current regulations
Teva Reaches Confidential Patent Settlement with Neos
27.12.18
|
CTech
The agreement will enable Teva to manufacture and sell a generic version of Neos’ ADHD drug Cotempla as of 2026